Skip to content

Diagnosis Prognosis and Mechanism of Sepsis induced DIC in Geriatric Patients

Diagnosis Prognosis and Mechanism of Sepsis induced DIC in Geriatric Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113411
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Gold Standard:The overt DIC diagnostic criteria proposed by the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee.
Index test:Thrombosis Four-Item Panel? (Thrombin-antithrombin complex, Plasmin-a2-plasmin inhibitor complex, Tissue plasminogen activator-plasminogen activator inhibitor-1 complex, Thrombomodulin)
sepsis-induced coagulopathy score

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >>= 65 years 2. Diagnosed with sepsis upon ICU admission (meeting the Sepsis 3.0 diagnostic criteria)

Exclusion criteria

Exclusion criteria: 1. Known congenital coagulation dysfunction 2. Presence of fulminant hepatitis, decompensated cirrhosis, or other severe liver diseases 3. Presence of primary hematological diseases 4. Coexisting conditions or medications that cause thrombocytopenia 5. Patients with major blood loss or active bleeding 6. End-stage patients 7. Use of the following medications: a. Heparin or heparin-like drugs administered within 24 hours prior to the study b. Warfarin administered within 7 days prior to the study c. New oral anticoagulants (including dabigatran, rivaroxaban, apixaban, etc.) administered within 3 days prior to the study d. Antiplatelet drugs administered within 7 days prior to the study e. Thrombolytic therapy administered within 3 days prior to the study f. Current use of Xuebijing or other traditional Chinese medicines that affect coagulation function

Design outcomes

Primary

MeasureTime frame
ISTH-overt Score;sepsis-induced coagulopathy score;Accuracy;

Secondary

MeasureTime frame
30-day all-cause mortality rate;ICU mortality rate;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactZhigang Chang

Beijing Hospital

zhigangchang@126.com+86 137 1899 6970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026